NHSPI_measure_metadata
Data source: Big Local News · About: big-local-datasette
5 rows where subdomain_name = "CUE"
This data as json, copyable, CSV (advanced)
Suggested facets: data_source, verbose_data_source, data_dates, limitations
| Link | rowid ▼ | obsid | index | item_code | domain_code | domain_name | domain_description | subdomain_code | subdomain_name | subdomain_description | subdomain_long_desc | measure_name | measure_description | measure_rationale | data_source | verbose_data_source | data_dates | limitations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98 | 98 | 224.0 | Index | 5.2.1 | 5.0 | CM | Countermeasure Management | 16.0 | CUE | Countermeasure Utilization & Effectiveness | The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. | M24 | Percent of children ages 19-35 months in the state receiving recommended routine childhood vaccinations, including four or more doses of diphtheria, tetanus, and pertussis vaccine, three or more doses of poliovirus vaccine, one or more doses of any measles-containing vaccine, and three or more doses of Hepatitis B vaccine | The measure is used by the Centers for Disease Control and Prevention (CDC) and states to monitor health status and is an important measure of achievement of immunization program objectives. The measure is a pre-event indicator of the capacity of the state's public and private immunization infrastructure needed to respond to an emerging vaccine-controllable disease. | CDC NIS | Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHC), National Immunization Survey (NIS) | 2012—2017 | The measure evaluates routine vaccines for preventable disease in pre-school age children, and may not reflect the vaccination rate for a severe emerging disease. |
| 99 | 99 | 225.0 | Index | 5.2.2 | 5.0 | CM | Countermeasure Management | 16.0 | CUE | Countermeasure Utilization & Effectiveness | The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. | M32 | Percent of seniors age 65 and older in the state receiving a seasonal flu vaccination | The measure focuses on adults aged 65+ who have had an influenza vaccination within the past year. This measure is used by the Centers for Disease Control and Prevention (CDC) and states to monitor health status and is an important measure of achievement of immunization program objectives. The measure is a pre-event indicator of the capacity of the state's public and private immunization infrastructure needed to respond to an emerging vaccine controllable disease. | CDC FluVaxView | Centers for Disease Control and Prevention (CDC), National Immunization Survey (NIS) and the Behavioral Risk Surveillance System (BRFSS), FluVaxView State, Regional, and National Vaccination Report | 2013—2018 | Vaccine effectiveness varies each year as a function of the accuracy in predicting the influenza strains covered by each year's vaccine. As a result, expected influenza protection and reduced demand on healthcare facilities may be marginal in the event of a major disaster. |
| 100 | 100 | 226.0 | Index | 5.2.3 | 5.0 | CM | Countermeasure Management | 16.0 | CUE | Countermeasure Utilization & Effectiveness | The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. | M33 | Percent of seniors age 65 and older in the state receiving a pneumococcal vaccination | The measure focuses on adults aged 65+ who have ever had a pneumonia vaccination. The measure should be viewed alongside other measures in the Countermeasures Utilization Effectiveness sub-domain as an indicator of pre-event capacity of the state's immunization system. | CDC BRFSS | Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System Survey Questionnaire (BRFSS). Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Survey data analyzed by PMO personnel. | 2012—2017 | The measure evaluates the recommended vaccine for preventable disease in seniors, and may not reflect the vaccination rate for a severe emerging disease. |
| 101 | 101 | 227.0 | Index | 5.2.4 | 5.0 | CM | Countermeasure Management | 16.0 | CUE | Countermeasure Utilization & Effectiveness | The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. | M34 | Percent of children aged 6 months to 4 years old in the state receiving a seasonal flu vaccination | The measure is used by Centers for Disease Control and Prevention (CDC) and states to monitor health status and is an important measure of the achievement of the state's immunization objectives. The measure serves as a pre-event indicator of the capacity of the immunization infrastructure in the state needed to respond to an emerging vaccine-controllable disease. | CDC NIS | Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHC), National Immunization Survey (NIS) | 2012—2018 | Vaccine effectiveness varies each year as a function of the accuracy in predicting the influenza strains covered by each year's vaccine. As a result, expected influenza protection and reduced demand on healthcare facilities may be marginal in the event of a major disaster. |
| 102 | 102 | 228.0 | Index | 5.2.5 | 5.0 | CM | Countermeasure Management | 16.0 | CUE | Countermeasure Utilization & Effectiveness | The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. | M35 | Percent of adults aged 18 years and older in the state receiving a seasonal flu vaccination | The measure focuses on influenza vaccination coverage for adults aged 18 to 64 years. This measure is used by the Centers for Disease Control and Prevention (CDC) and states to monitor health status and is an important measure of achievement of immunization program objectives. The measure is a pre-event indicator of the capacity of the state's public and private immunization infrastructure needed to respond to an emerging vaccine-controllable disease. | CDC FluVaxView | Centers for Disease Control and Prevention (CDC), National Immunization Survey (NIS) and the Behavioral Risk Surveillance System (BRFSS), FluVaxView State, Regional, and National Vaccination Report | 2013—2018 | Vaccine effectiveness varies each year as a function of the accuracy in predicting the influenza strains covered by each year's vaccine. As a result, expected influenza protection and reduced demand on healthcare facilities may be marginal in the event of a major disaster. |
Advanced export
JSON shape: default, array, newline-delimited
CREATE TABLE [NHSPI_measure_metadata] ( [obsid] TEXT, [index] TEXT, [item_code] TEXT, [domain_code] TEXT, [domain_name] TEXT, [domain_description] TEXT, [subdomain_code] TEXT, [subdomain_name] TEXT, [subdomain_description] TEXT, [subdomain_long_desc] TEXT, [measure_name] TEXT, [measure_description] TEXT, [measure_rationale] TEXT, [data_source] TEXT, [verbose_data_source] TEXT, [data_dates] TEXT, [limitations] TEXT );